Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-26 @ 3:54 AM
Study NCT ID:
NCT00070018
Status:
COMPLETED
Last Update Posted:
2022-01-11
First Post:
2003-10-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
S0313 Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
Sponsor:
SWOG Cancer Research Network
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2010-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-01-08
Completion Date Type:
ACTUAL
First Submit Date:
2003-10-03
First Submit QC Date:
None
Study First Post Date:
2003-10-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-03-05
Results First Submit QC Date:
None
Results First Post Date:
2012-04-03
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-12-22
Last Update Post Date:
2022-01-11
Last Update Post Date Type:
ACTUAL